GLP-1RA reduces risk of CV events associated with overweight and obesity3' education - Nov. 11, 2023 - Michael Lincoff, MD - Cleveland, OH, USA
This video was recorded during the AHA Scientific Sessions 2023 in Philadelphia, PA, USA.
Michael Lincoff, MD is an interventional cardiologist and Vice Chairman for Research of the Department of Cardiovascular Medicine at the Cleveland Clinic in Cleveland, OH, USA. He is also the Director of the Cleveland Clinic Coordinating Center for Clinical Research.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.